1. Introduction {#s0005}
===============

Collagens are crucial for the development of form and function in multicellular animals. In mammals, increased collagen deposition occurs in response to injury as part of the tissue repair process ([@bb0160]). Collagen accumulation in humans, typically referred to as tissue fibrosis, is a clinically important feature of chronic disease states as well as ageing. In both humans and mammalian models, tissue fibrosis is linked to organ dysfunction and an increased risk of mortality. Understanding the molecular genetics of collagen deposition and fibrosis is therefore an important step towards developing anti-fibrotic therapies. Fibrosis-related proteins and the signalling pathways leading to fibrosis show a high degree of genetic and functional conservation in the animal kingdom ([@bb0145], [@bb0070], [@bb0135]). The fruit or vinegar fly, *Drosophila melanogaster* expresses several collagen genes, as well as matricellular proteins required for the assembly of extracellular matrices ([@bb0165], [@bb0100]). Collagens and associated matricellular proteins are important mediators of cardiac development in *Drosophila* ([@bb0070], [@bb0035], [@bb0045]). Despite *Drosophila* being highly amenable to studies of age-related cardiac decline ([@bb0155], [@bb0020], [@bb0090], [@bb0095], [@bb0120], [@bb0105]), there are currently no studies examining collagen deposition in the ageing heart.

SPARC (Secreted Protein Acidic and Rich in Cysteine) is a well-characterised collagen binding matricellular protein involved in tissue fibrosis ([@bb0150], [@bb0005]). SPARC is evolutionarily and functionally conserved and known to mediate collagen deposition in *Drosophila* embryos ([@bb0100]). *SPARC* expression is increased in a number of clinically important settings and accumulates (along with other extracellular matrix (ECM) proteins) in the ageing mammalian heart ([@bb0010], [@bb0025]), suggesting it may play a role in cardiac dysfunction in human ageing. Recent findings indicate that reduced *SPARC* expression can correct cardiomyopathy in *Drosophila* ([@bb0070]). In addition, reduced expression of the ECM proteins Laminin, Viking and Pericardin in the *Drosophila* heart can impede age-related cardiac dysfunction ([@bb0135]). Despite this knowledge, there is no data on whether ECM proteins accumulate within the ageing *Drosophila* heart.

Embryonic and larval development of *Drosophila* is dependent on the expression of type-IV collagen α2 and α1 chains encoded by *Viking* and *Cg25C*, as well as Multiplexin (an ortholog of human *COL18A1*) and the heart specific type-IV-like collagen, Pericardin; the latter two proteins being integral to cardiac development ([@bb0035], [@bb0065]). Although Pericardin was initially described as a matrix forming type-IV-like collagen, it also adopts prominent fibre-like structures and acts as a 'tendenous' bridge between the heart and alary muscles. How these collagenous fibres are formed and maintained remains largely uncharacterised.

In humans and mammalian models, fibrosis is regarded as an accumulation of extracellular matrix in a given tissue. Most attention has focused on fibril forming collagens, however fibrosis is complex and outcomes in terms of organ function are affected not only by the gross accumulation of collagen subtypes and other ECM proteins but also by the ratios of different collagens and ECM proteins ([@bb0075]). Experimental evidence indicates that *Drosophila* may be a tractable model with which to study the mechanisms leading to tissue fibrosis in humans. For example, an accumulation of collagen in and around *Drosophila* adipocytes alters innate immunity ([@bb0175]) whereas diet-dependent changes to *Drosophila* heart function are associated with cardiac fibrosis ([@bb0115]). These findings make *Drosophila* a valuable tool with which to understand and identify mechanisms regulating collagen deposition and its impact on organ function. Given that collagen turnover (i.e. the expression, deposition and degradation of collagen) as well as the ageing process are evolutionarily conserved, it was predicted that collagen may accumulate as part of the ageing process in the *Drosophila* heart model and that *SPARC* may mediate this process.

In this report we describe the accumulation of collagen in the ageing *Drosophila* heart and show that this accompanies the well-described age-dependent functional decline of the fly\'s heart. It is also shown that *SPARC* heterozygous flies have a longer lifespan as well as extended cardiac health span. Despite this, the accumulation of collagen around the heart does not seem to be affected by reduced *SPARC* expression; whereas, SPARC over-expression led to cardiomyopathy and Pericardin accumulation. The findings support the idea that age-related fibrosis in mammals is an evolutionarily conserved process which can be studied in simpler, genetically tractable models.

2. Materials and methods {#s0010}
========================

2.1. Stock chemicals and fly husbandry {#s0015}
--------------------------------------

Picrosirius red and all stock chemicals were from Sigma (Poole, Dorset, UK). The *Canton Special*, *w^1118^*, *yw*, *SPARC^MI00329^* (with a MiMIC insertion in the 5-prime region of the *SPARC* locus; described in ([@bb0140])) and *Viking-GFP* strains were obtained from the Bloomington Drosophila Stock Centre. The *Dorothy*-*Gal4* line was described previously ([@bb0085]) and is used to drive the expression of genes downstream of a UAS (upstream activation sequence) element. The *UAS*-*SPARC* line was described in ([@bb0100]). Flies were reared and maintained on a standard cornmeal-yeast-agar diet under 12 h:12 h light:dark cycles at 25 °C. *SPARC^MI00329^* were backcrossed to a *yw* background for \> 6 generations and then outcrossed once to the *w^1118^* line to generate heterozygous flies for phenotyping and lifespan studies.

2.2. Lifespan studies {#s0020}
---------------------

Ten male or female flies within 1 day of eclosion were collected and transferred to fresh vials with standard diet. Five to ten vials per trial were prepared. At least two trials were conducted for each genotype. Vials were maintained on their side and flies tipped to fresh food twice per week for the duration of the lifespan studies. All vials were maintained under 12 h:12 h light:dark cycles at 25 °C. Lifespan data is presented as Kaplan-Meier plots as well as the mean of the median (the point at which 50% of the population had died) and maximum lifespan (± SEM).

2.3. Histochemistry, imaging and qPCR {#s0025}
-------------------------------------

Adult flies were anaesthetised by brief exposure to CO~2~, hearts were exposed by dissection and fixed using 1% formaldehyde for 15 min. Picrosirius red dye was then added for 5 min at ambient temperature and rinsed from dissected hearts using acidified water (1% acetic acid in water). Picrosirius red comprises sulphonic acid and stains the basic amine residues of most proteins but preferentially stains collagens because of their abundance and the large number of glycine residues. Colour phase images were captured on a Leica DMLB fitted with a Leica DC300 colour camera, images were taken using μManager software ([@bb0050]). Pericardin was imaged after staining dissected hearts with the mouse-anti Pericardin monoclonal antibody clone EC11 ([@bb0170]) (Developmental Studies Hybridoma Bank, University of Iowa) followed by a fluorescently-tagged secondary antibody. Fluorescence images were taken using a Zeiss LSM 710 confocal microscope and images quantified using ImageJ by drawing a line across a region of interest and recoding the maximum fluorescence signal.

2.4. Analysis of cardiac Pericardin {#s0030}
-----------------------------------

Hearts stained with anti-Pericardin antibodies were imaged by confocal microscopy and z-projections of stacks analysed in ImageJ. The same number of z-projected stacks was sued for each genotype and age. All images were of the distal region of the heart comprising approximately 2/3 of the total heart, where the majority of anti-Pericardin staining is found. Images were thresholded and the percentage of Pericardin positive signal quantified as a percentage of the total image. For measurement of Pericardin fibre thickness, single confocal image stacks were used and at least six fibre measurements were taken from four different flies. Data are presented as the mean fibre thickness (± SEM).

2.5. Heart function analysis {#s0035}
----------------------------

Adult flies were anaesthetised by brief exposure to Triethylamine vapour (20 μL of a 50% solution made in 50% ethanol/water, placed into the underside of a fly vial\'s cotton cap). Flies were dissected as described previously ([@bb0030]) and imaged using a Zeiss Axiolab microscope fitted with a water immersion 10 × objective, linked to a Myocam S (Ionoptix Ltd., Ireland) high speed video camera. The beating heart was imaged for 10--20 s at 120 frames per second (fps) and heart function analysed using SOHA ([@bb0055]). For heart analysis involving SPARC over-expression, video capture was performed with a Ximea XDi camera and a frame rate of 25 fps.

2.6. Western Blotting {#s0040}
---------------------

For each lane 10 female hearts were harvested and directly lysed in 10 μL Ripa buffer (Sigma, Poole, UK). Polypeptides were separated on a 4--20% SDS-page gel and transferred to a PVDF membrane. The membrane was then probed with anti-pericardin (DSHB, EC11) and anti-actin (DSHB JLA20) antibodies followed by secondary antibodies conjugated to alkaline phosphatase. Secondary antibodies were detected using NBT (nitro-blue tetrazolium chloride) with BCIP (5-bromo-4-chloro-3′-indolyphosphate p-toluidine salt).

2.7. Statistics {#s0045}
---------------

When two means were compared, an unpaired two-tailed student\'s *t*-Test was applied to establish the P-value. When mean data for genotype and age were compared in an experiment, two-way ANOVA was used. Graphs show mean ± SEM.

3. Results {#s0050}
==========

3.1. Overall collagen and collagen-IV deposition increases in older flies {#s0055}
-------------------------------------------------------------------------

To assess collagen deposition in the heart two approaches were initially used. Firstly picrosirius red, a histochemical dye used widely to quantify collagen in mammalian tissue section was used to stain the heart of one-week and six-week-old wild type (*Canton S*) *Drosophila*. The adult *Drosophila* heart exhibited extensive pink-red staining that became more intense in older flies (inset [Fig. 1](#f0005){ref-type="fig"}A and B). Quantification of the signal was not possible due to older flies developing a red-brown pigmentation in their cuticle which affected colour-based image analysis. The second approach used flies expressing a fluorescently tagged collagen-IV protein encoded by the *viking* gene ([@bb0110]). This reporter system has been used to visualise collagen-IV during embryogenesis and egg morphogenesis and reliably reports Viking protein distribution in basement membranes ([@bb0125], [@bb0060]). In accordance with the picrosirius red results, Viking-GFP fluorescence was abundant along the heart of adult flies and particularly intense at the 1st, 2nd and 3rd valve pairs (arrow denotes the 2nd valve pair in [Fig. 1](#f0005){ref-type="fig"}A), the distal heart (asterisks [Fig. 1](#f0005){ref-type="fig"}A and B) and the longitudinal muscles, especially those overlying the conical chamber (arrowheads, [Fig. 1](#f0005){ref-type="fig"}A and B). As for the picrosirius red result, the Viking-GFP signal at the distal heart, valve and longitudinal muscles ([Fig. 1](#f0005){ref-type="fig"}C--E) was markedly increased in older flies (Figs. F--H). Unlike the picrosirius red signal, the Viking-GFP fluorescence signal was amenable to quantification and recorded as significantly increasing at the distal heart, valves and longitudinal muscles of one and six-week-old flies ([Fig. 1](#f0005){ref-type="fig"}I--K; P \< 0.01). Additionally, valve cells exhibited age-dependent remodelling ([Supplemental Fig. S1](#ec0005){ref-type="supplementary-material"}). This change to valve morphology in *Drosophila* does not appear to have been documented before but may reflect the senescence-related changes known to occur to human aortic valve leaflets ([@bb0040]).

3.2. Cardiac Pericardin accumulation {#s0060}
------------------------------------

In addition to Collagen-IV quantification, the level of Pericardin was quantified in one and six-week old flies ([Fig. 2](#f0010){ref-type="fig"}). Pericardin is a type-IV-like collagen associated exclusively with the insect dorsal vessel ([@bb0035]). Hearts of *w^1118^* flies stained with antisera to Pericardin exhibited a complex network of overlapping Pericardin fibres, which were especially concentrated at the distal heart region ([Fig. 2](#f0010){ref-type="fig"}A) and between adjacent nephrocytes and the heart tube (not shown). The immunofluorescence signal for Pericardin in six week old flies was increased relative to younger, one week old flies ([Fig. 2](#f0010){ref-type="fig"}B; P \< 0.01). Western blot analysis of total cell lysates from isolated hearts confirmed an increased level of cardiac Pericardin on older flies ([Fig. 2](#f0010){ref-type="fig"}C and D; P \< 0.05). In addition, Pericardin fibre thickness was analysed in single confocal sections and also found to be greater in older flies ([Fig. 2](#f0010){ref-type="fig"}E--H; P \< 0.05).Fig. 1The Viking-GFP signal accumulates at all regions of the ageing heart.(A and B) The heart of adult flies expressing a Viking-GFP fusion protein shows an increase of signal over six weeks. This insets show the signal from the histological stain picrosirius red of similarly aged *Canton S* wild type flies. The Viking-GFP signal is increased at the valve (arrows), conical chamber (arrowheads) and distal heart (asterisk); scale bar = 150 μm. Confocal images and quantified data of the Viking-GFP signal at the distal heart (C, F and I), valves (D, G and J) and longitudinal muscles of the conical chamber (E, H and K) of one and six week old flies. V = valves. Quantified data was obtained from four to six individual flies at each age. Mean fluorescence is expressed in arbitrary units ± SEM. P values were determined by *t*-Test.Fig. 1Fig. 2Pericardin levels increase in the ageing heart.(A) Confocal micrographs of z-projected stacks through the distal region of the hearts in flies of different ages stained with antisera to Pericardin. (B) The amount of Pericardin fluorescence signal in 1 wk and 6 wk-old flies; n = 3; \*P \< 0.01. (C) Western blot of whole cell lysate of hearts from young (1 week) and older flies (6 weeks) stained with antibodies raised to Pericardin. Actin was used as a loading control. (D) Quantification of polypeptide band intensity relative to the control (Actin). Data are the mean (± SEM) of measurements from three independent experiments; \*P \< 0.05. (E--G) A single confocal slice through the distal region of the heart of young (1 week) and older flies (6 weeks); scale bars = 100 μm in E; 10 μm in F. Boxes depict examples of regions used for quantifying Pericardin fibre thickness. (H) Pericardin fibre thickness in young (1 week) and older flies (6 weeks). Data are the mean (± SEM) of fibres from at least 6 fibre measurements from four individual flies at each age. \*P \< 0.01.Fig. 2

3.3. Reduced *SPARC* expression is associated with extended lifespan {#s0065}
--------------------------------------------------------------------

It is well established that, like the mammalian heart, there is an age-dependent decline in cardiac function in *Drosophila* ([@bb0155]). In addition, there is an association between increased Pericardin deposition and abnormal cardiac function in a diet-induced *Drosophila* cardiomyopathy model ([@bb0115]). Recent evidence from the *Drosophila* heart model indicates that *SPARC* mediates the development of a cardiomyopathy caused by disruption of the fly\'s kidney-like nephrocytes ([@bb0070]). As *Drosophila* and mammalian SPARC are both involved in collagen deposition, we asked whether a hypomorphic allele of *Drosophila SPARC* may alter the age-dependent decline in cardiac function, age-dependent collagen deposition in the fly heart or both.

The mutant *SPARC* allele is caused by a transgene insertion that reduces the gene\'s expression by 60% in heterozygous flies ([@bb0070]). Both female and male *SPARC* heterozygous flies had extended lifespan compared to controls ([Fig. 3](#f0015){ref-type="fig"}). Maximum and median lifespan for female *SPARC* heterozygotes were 72 days and 63 days, nine and fifteen days longer than control\'s ([Fig. 3](#f0015){ref-type="fig"}B & C; P \< 0.01). Similarly, the maximum and median lifespan of male *SPARC* heterozygous flies were 66 days and 52 days; nine and ten days longer than controls ([Fig. 3](#f0015){ref-type="fig"}E & F; P \< 0.01).Fig. 3Extended lifespan in *SPARC* heterozygous flies.(A) Representative Kaplan-Meier plot of survival over time for flies of the control (w1118, black line) and SPARC heterozygous genotypes (red line). Data is from females for each genotype. (B & C) Quantified data for maximum and median lifespan. Data represents mean of two independent trials using five groups of 15 flies of each genotype per trial. Data are presented as the mean (± SEM) for each genotype. \*P \< 0.01.Fig. 3

3.4. Impact of reduced *SPARC* expression on the age-dependent decline of heart function {#s0070}
----------------------------------------------------------------------------------------

To establish if SPARC mediated the age-dependent decline of cardiac function, heart function was monitored at one, three and six weeks in control and *SPARC* heterozygous flies ([Fig. 4](#f0020){ref-type="fig"}). The cardiac function of control flies (*w^1118^*) exhibited an age-dependent decline as expected, whereas *SPARC* heterozygous flies showed no apparent change to cardiac function. Example m-modes (two-dimensional images of the heart\'s contractions over time) show regular beating of the heart in young (one week old control and SPARC heterozygous flies; [Fig. 4](#f0020){ref-type="fig"}A). There was a significant change to the rhythmicity of cardiac contractions in six week old controls, characterised by a longer cardiac cycle and periods of arrhythmia. This age-dependent change was not as apparent in older *SPARC* heterozygous flies (lower m-modes in [Fig. 4](#f0020){ref-type="fig"}A), which exhibited cardiac function comparable to that of younger flies. Quantification of heart rate, heart period, diastolic and systolic intervals as well as the arrhythmia index (a measure of beat-to-beat variability) confirmed there was an age-dependent change to all parameters in controls but not *SPARC* heterozygous flies ([Fig. 4](#f0020){ref-type="fig"}B; P \< 0.01 for age-dependent decline in controls; whereas there was no significant difference in *SPARC* heterozygous flies as they aged). In terms of cardiac morphology and contraction distance (FS, fractional shortening), there was a small but significant difference between the genotypes\' heart diameter at diastole (EDD) but not systole (ESD; [Fig. 4](#f0020){ref-type="fig"}B; P \< 0.01). However, neither genotype showed any age-related changes to these three parameters (P \< 0.05).Fig. 4Extended cardiac health span in *SPARC* heterozygous flies.(A) The adult beating heart was imaged in semi-intact preparations and functional parameters measured from videos captured at \~ 120 frames per second. The m-modes show heart contractions over a 12 s period. M-modes from two different flies of each genotype, control (*w^1118^*) and mutant (*SPARC^MI00329^* heterozygotes) are show for each age (1 and 6 weeks old). Older wild type flies exhibit a disrupted heart rhythm, however this does not occur in *SPARC^MI00329^* heterozygotes. (B) Quantified data for heart function showing that the age-dependent decline in heart function recorded in the wild types (black lines) does not develop in *SPARC^+/−^* flies (red lines). Graphs show mean ± SEM for each parameter. \*P \< 0.001, there is an age-related change in the parameter; ^\#^P \< 0.01 there is a difference between genotypes by 2-way-ANOVA, n = 20--50 flies per genotype, per time-point.Fig. 4

3.5. Over-expression of *SPARC* is sufficient to cause cardiomyopathy and increase Pericardin deposition {#s0075}
--------------------------------------------------------------------------------------------------------

To assess whether *SPARC* expression is sufficient to cause cardiac dysfunction *SPARC* was over-expressed using *Dorothy*-*Gal4* in pericardial nephrocytes (large, kidney-like cells that lie adjacent to the heart). Within one week of eclosion, cardiac function was severely disrupted in flies over-expressing *SPARC*. Heart dysfunction mirrored the phenotype of older flies, with the majority showing periods of arrhythmia (71% of experimental flies versus 0% of controls; [Fig. 5](#f0025){ref-type="fig"}A and B) and a very slow heart rate ([Fig. 5](#f0025){ref-type="fig"}C; P \< 0.01). Pericardial nephrocytes are also a major source of Pericardin, and over-expression of *SPARC* in the nephrocytes caused a significant (\~ 4-fold) increase to Pericardin deposition around nephrocytes and the heart ([Fig. 5](#f0025){ref-type="fig"}D--F; P \< 0.01).Fig. 5Over-expression of *SPARC* causes cardiomyopathy and increased Pericardin deposition.(A) M-modes showing the impact of *SPARC* over-expression on heart function at one week of age (from videos captured at 25 frames per second). (B) The percentage of hearts that were arrhythmic in controls ('C', the *UAS*-*SPARC* parent line outcrossed to *w^1118^*) versus *SPARC* overexpression flies (driven by the *Dorothy* enhancer; 'UAS-SPARC'); n = 7--10 flies for each genotype. (C) Mean heart rate (± SEM) for the control and *SPARC* over-expression flies at one week. n = 7 flies for each genotype; \*P \< 0.01. (D) Confocal micrographs of adult 1 week old hearts stained with wheat germ agglutinin (red, to highlight cell surfaces) and antibodies to Pericardin (cyan); scale bar = 100 μm. (E) Higher magnification of hearts stained with WGA and Pericardin antibodies; scale bar = 50 μm. (F) Percentage coverage of heart staining positive for Pericardin (mean, ± SEM); n = 5; \*P \< 0.01.Fig. 5

3.6. No evidence for reduced age-dependent collagen accumulation in *SPARC* heterozygous flies {#s0080}
----------------------------------------------------------------------------------------------

The impact of *SPARC* modulation on heart function was followed up by an analysis of collagen deposition in one and six-week-old control and *SPARC* heterozygous flies. There was no apparent abnormality to the fibrous Pericardin network in *SPARC* heterozygous flies compared to controls, at either one or six weeks of age ([Fig. 6](#f0030){ref-type="fig"}A). Quantification of fibre width in controls corroborated earlier findings, with older flies having thicker fibres than younger flies ([Fig. 6](#f0030){ref-type="fig"}B); however the same was true for *SPARC* heterozygous flies which also exhibited thicker Pericardin fibres in older flies. Additionally, the Viking-GFP signal in the heart valves of control and *SPARC* heterozygous flies was similar at all ages (1, 2, 4 and 6 weeks; [Fig. 6](#f0030){ref-type="fig"}C; P \> 0.05). Finally, Pericardin was quantified in young and old flies by western blot and found to be similar in young flies of each genotype and to increase comparably in both genotypes ([Fig. 6](#f0030){ref-type="fig"}D--F).Fig. 6The levels of Viking and Pericardin in aged *SPARC* heterozygous hearts.(A) Confocal slices through the distal region of the hearts of young (1 week) and older (6 week) control (*w^1118^*) and SPARC heterozygous flies (*SPARC^MI00329^*) stained with antibodies to Pericardin. (B) Mean (± SEM) Pericardin fibre thickness in flies of different ages and genotype as described in the figure. ns = P \> 0.05. n = 6 measurement from 4 four individual flies. (C) Mean (± SEM) of the Viking-GFP signal at the valves of flies of different ages and genotype (*w^1118^*, black lines and *SPARC^MI00329^*, red lines). *ns* = P \> 0.05. n = 6--10 flies of each age and genotype. (D) Western blot of heart tissue stained with Pericardin antibodies and actin as a loading control. (E) Quantification of anti-Pericardin western blot band intensity using at one week of age; *ns* = not statistically different from control. (F) Quantified data showing fold change in Pericardin band intensity; n = three blots; \**P* \< 0.05 for there being a difference in Pericardin at 6 weeks compared to 1 week.Fig. 6

4. Discussion {#s0085}
=============

This study examined collagen deposition in the ageing *Drosophila* heart. This was done using a well-known histological stain that detects collagen (picrosirius red), a collagen-IV reporter fusion protein (Viking-GFP) and immunological detection of the type-IV-like collagen, Pericardin. The work tested the hypothesis that age-related changes to either cardiac function or cardiac collagen accumulation may be mediated by the matricellular protein, SPARC. There was evidence for increased collagen deposition in the heart that accompanied cardiac dysfunction. Age-dependent cardiac dysfunction was prevented in SPARC heterozygous flies, however there was no evidence of reduced collagen accumulation. SPARC over-expression was sufficient to cause cardiomyopathy in young flies and this accompanied increased Pericardin deposition. We conclude that the *Drosophila* heart develops a fibrosis-like phenotype as it ages and that SPARC mediates cardiac ageing and Pericardin accumulation. These findings suggest the existence of evolutionarily-conserved mechanisms of age-related collagen deposition and that the *Drosophila* model may contribute to the study of age-related fibrosis in humans. However, it remains unclear how SPARC and the accumulation of collagen are linked to cardiac dysfunction in *Drosophila*.

Fibrosis can be regarded as an accumulation of extracellular matrix (ECM) in a given tissue. In humans and mammalian models, fibrosis typically develops as part of a tissue repair process, chronic inflammatory disease or ageing. Fibrotic outcomes in terms of organ function appear to be determined not only by the gross accumulation of ECM but also by the ratios of different ECM proteins ([@bb0075]). The fact that we observed thickening of Pericardin fibres and an accumulation of type-IV collagen is consistent with the development of a fibrosis-like phenotype in the ageing *Drosophila* heart.

Accompanying the fibrosis-like phenotype was a decline of cardiac function. Cardiac dysfunction in ageing was expected and reported previously by others ([@bb0155], [@bb0080]). It is known that collagen accumulates in the ageing mouse myocardium and that this correlates with increased SPARC protein levels, as well as cardiac stiffness ([@bb0010]). These age-related changes to collagen and cardiac stiffness are blunted in *SPARC*-null animals ([@bb0010]). Similarly, in mice heterozygous for *SPARC*, collagen IV levels do not increase in ageing ventricles ([@bb0025]). There is recent evidence that *SPARC* mediates the development of cardiomyopathy in *Drosophila* ([@bb0070]) and that reduced expression of extracellular matrix (ECM) proteins can prevent cardiac ageing in flies ([@bb0135]). In accordance with these findings it was hypothesised that reduced *SPARC* expression may prevent the age-related decline of cardiac function in *Drosophila*, possibly by modulating ECM deposition.

Using video microscopy of semi-intact heart preparations, it was found that reduced *SPARC* expression prevented the age-dependent decline of cardiac function. In addition, SPARC heterozygous flies had extended median and maximal lifespan compared to controls. Hence, reduced *SPARC* contributes to a longer life with an accompanying extension of cardiac health-span in *Drosophila*. In contrast, over-expression of *SPARC* in pericardial nephrocytes was sufficient to cause a severe a cardiomyopathy in young flies that reflected the phenotype of the aged heart. This cardiomyopathy accompanied the accumulation of Pericardin, indicating that increased *SPARC* expression can promote Pericardin deposition in *Drosophila*.

In contrast to the prediction that reduced *SPARC* may mediate the accumulation of cardiac collagen in ageing flies and the over-expression result, reduced *SPARC* expression was recorded as not having an impact on the quantity of Viking or Pericardin deposited around the heart at any age. Both control and *SPARC* heterozygous flies had similar levels of cardiac Viking or Pericardin at one and six weeks of age, hence both genotypes accumulated the collagens at a similar rate as they aged. This suggests that *SPARC*\'s impact on cardiac health-span may depend on mechanisms distinct to collagen accumulation. However, this conclusion is offered tentatively because there is a wealth of data indicating that *SPARC* mediates collagen assembly in other models ([@bb0015]). Hence, it is not possible to conclude that gross accumulation of collagen around the ageing heart was the reason for the decline in cardiac function. One mechanism by which *SPARC* may affect cardiac ageing is by activation of the Integrin-Linked Kinase pathway (ILK). It is known that mammalian SPARC directly interacts with β-1 integrin and activates ILK signalling ([@bb0150]). A recent study in *Drosophila* established that ILK regulates cardiac ageing ([@bb0120]). It is therefore plausible that reduced *SPARC* may prevent cardiac ageing by reducing cardiac ILK signalling. However, this problem may be somewhat intractable because earlier work demonstrated that cardiac-restricted knock-down of *SPARC* has deleterious effects on heart development and function ([@bb0070]). Additionally, the glycation of collagen (the formation of cross-linkages between collagen fibres) increases as organisms age and this affects basement membrane flexibility ([@bb0130]). Future work will examine whether such qualitative changes to collagens occur in ageing *Drosophila* model and whether they impact cardiac function.

In summary, the ageing *Drosophila* heart develops a fibrosis-like phenotype typified by an accumulation of collagen-IV (Viking) and the type-IV-like collagen, Pericardin. This is associated with age-dependent decline in cardiac function. Whilst reduced *SPARC* can ameliorate the decline of cardiac function it does so by a mechanism that appears independent of the gross changes to collagen accumulation measured in this study. The findings imply that the *Drosophila* heart can be used to model the genetic pathways contributing to age-dependent fibrosis in higher organisms, including humans.

The following is the supplementary data related to this article.Fig. S1Morphometric analysis of the valve cells in ageing flies. Confocal micrographs of cardiac valves were used to measure valve width and length in young (1 week old) and older (6 week old) flies. Both parameters were reduced in older flies (\*P \< 0.01), n = 12--14 valves per age.Fig. S1
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